Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacologic Treatment of Obesity in the Context of Type 2 Diabetes

Current Diabetes Reports(2026)10.1007/s11892-026-01626-5Source: DataRank Database

Pharmacologic Treatment of Obesity in the Context of Type 2 Diabetes is a research paper published in Current Diabetes Reports (2026). On theSindex it has a DataRank of 0.165. It has been cited 2 times.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 12.84)OA: closedTopics (25)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (2)

Anastassia Amaro ORCID,Caterina Conte ORCID

Live enrichment

PubMed:41973192 OpenAlex:https://openalex.org/W7153987091

Italian Ministry of Health

Grant: Ricerca Corrente IRCCS MultiMedica

FWCI

12.84

Citation Percentile

1.0%

Citation Trend

2026

closedLicense: https://www.springernature.com/gp/researchers/text-and-data-mining

publisherhttps://link.springer.com/content/pdf/10.1007/s11892-026-01626-5.pdf

publisherhttps://link.springer.com/article/10.1007/s11892-026-01626-5

journalhttps://doi.org/10.1007/s11892-026-01626-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41973192

Fields of Study

Diabetes Treatment and ManagementCardiovascular Function and Risk FactorsBariatric Surgery and Outcomes

MeSH Terms

DiabesityDiabetes Mellitus, Type 2HumansHypoglycemic AgentsObesityWeight LossAnti-Obesity AgentsIncretins

Keywords

Type 2 diabetesWeight lossContext (archaeology)ObesityGlycemicPharmacotherapyIncretinDiabetes mellitusIncretin TherapyCardiometabolic RiskSemaglutideTirzepatideSarcopenic DiabetesGlp‑1 Agonists

Sustainable Development Goals

SDG 0: Good health and well-being

Pharmacologic Treatment of Obesity in the Context of Type 2 Diabetes

FAIR Checklist

DataRank Breakdown

Authors (2)

Funding (1 grants)

Impact

Open Access

Topics